Lipocine Revenue and Competitors
Estimated Revenue & Valuation
- Lipocine's estimated annual revenue is currently $3.5M per year.
- Lipocine's estimated revenue per employee is $145,833
- Lipocine's total funding is $66.7M.
Employee Data
- Lipocine has 24 Employees.
- Lipocine grew their employee count by 0% last year.
Lipocine's People
Name | Title | Email/Phone |
---|
Lipocine Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $132M | 368 | N/A | N/A | N/A |
What Is Lipocine?
Lipocine is a specialty pharmaceutical company focused on developing innovative oral treatment alternatives for use in men’s and women’s health using its proprietary drug delivery technologies. Lipocine product development pipeline entails repositioning of established drugs with significantly improved patient compliance through an efficient 505(b) (2) regulatory pathway strategy.
keywords:Biotechnology$66.7M
Total Funding
24
Number of Employees
$3.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Lipocine News
Comparatively, Lipocine has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Analyst Ratings. This is a...
SALT LAKE CITY, April 11, 2022 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on neuroendocrine and...
Lipocine Inc. shares were down 14% to $1.56 after the company said that Antares Pharma Inc. said the U.S. Food and Drug Administration has...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 24 | 0% | N/A |
#2 | $3.7M | 24 | 9% | N/A |
#3 | $6M | 24 | 0% | N/A |
#4 | $4.9M | 24 | 4% | N/A |
#5 | $1.7M | 24 | 50% | N/A |